Azitra Inc

NYSE American:AZTRUnited States

Nov 12, 2024

Show headlines and story abstract

• Azitra, Inc. Announces Q3 2024 Financial Results and Provides Business Updates, from 5:05PM ET on Tuesday Nov 12, 2024 by PR Newswire

  5:05PM ET on Tuesday Nov 12, 2024 by PR Newswire
  Companies Mentioned: AZTR

  Azitra, Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today reported financial results for the three months ended September 30, 2024 and provided a business update.

• Press Release: Azitra, Inc. Announces Q3 2024 Financial Results and Provides Business Updates, from 5:05PM ET on Tuesday Nov 12, 2024 by Dow Jones

  5:05PM ET on Tuesday Nov 12, 2024 by Dow Jones
  Companies Mentioned: AZTR

• Azitra, Inc. Announces Q3 2024 Financial Results and Provides Business Updates, from 5:05PM ET on Tuesday Nov 12, 2024 by Dow Jones

  5:05PM ET on Tuesday Nov 12, 2024 by Dow Jones
  Companies Mentioned: AZTR
  --------------- -------------- Total other income (expense) 1,919,716 50,443 --------------- -------------- Net loss before income taxes (1,009,491) (1,943,289) Income tax expense - - --------------- -------------- Net loss $ (1,009,491) (1,943,289) Dividends on preferred stock - - --------------- -------------- Net loss attributable to common shareholders $ (1,009,491) (1,943,289) Net loss per Share, basic and diluted $ (.17) $ (4.82) Weighted average common stock outstanding, basic and diluted 5,814,350 403,255 =============== ============== Condensed Balance Sheets (Unaudited) September 30, December 31, 2024 2023 ------------- ------------- Assets Current Assets: Cash and cash equivalents $ 7,260,234 $ 1,795,989 Other receivables 9,923 223,474 Prepaid expenses and other current assets 364,673 516,116 ------------ ------------ Total current assets $ 7,634,830 $ 2,535,579 ------------ ------------ Property and equipment, net 638,107 710,075 Other assets 1,504,562 1,869,832 ------------ ------------ Total assets $ 9,777,499 $ 5,115,486 ------------ ------------ Liabilities, and stockholders' equity Current liabilities: Accounts payable $ 588,460 $ 897,272 Current financing lease liability 15,687 14,600 Current operating lease liability 276,839 307,655 Accrued expenses 486,981 383,668 ------------ ------------ Total current liabilities 1,367,967 1,603,195 ------------ ------------ Long-term financing lease liability 14,266 26,169 Long-term operating lease liability 336,556 537,523 Warrant liability 457 35,453 ------------ ------------ Total liabilities 1,719,246 2,202,340 Stockholders' equity Common stock 763 40 Additional paid-in capital 63,230,182 51,510,269 Accumulated deficit (55,172,692) (48,597,163) ------------ ------------ Total stockholders' equity 8,058,253 2,913,146 Total liabilities and stockholders' equity $ 9,777,499 $ 5,115,486 ------------ ------------